The IMA recently revealed a new booklet named 'Headache Algorithm: A guide to Headache Management' which focuses on managing headache disorders in India. This effort arrives at a critical moment as headache control is the primary reason for...
In order to expedite research on new remedies for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), Thermo Fisher Scientific Inc., a global leader in serving science, is teaming up with the National Cancer Institute (NCI)...
Inspira Technologies, an innovative medical technology firm, has revealed that the INSPIRA ART100, an extracorporeal membrane oxygenation and cardiopulmonary bypass system, has been granted approval by the Israeli Ministry of Health for medical...
Medical, Inc., an innovative biopharmaceutical business developing unique, long-term medication implants, said that the first clinical study in the NPM-115 program is expected to begin in Australia in the fourth quarter of 2024, subject to...
The National Medical Products Administration of China has approved CSPC Pharmaceutical Group's respiratory syncytial virus (RSV) vaccine candidate for human clinical trials, the company announced. RSV, which causes symptoms similar to a cold but...
The Swedish biopharma company BioArctic AB announced that its partner Eisai has been granted approval by the Department of Health in Hong Kong for the treatment of Alzheimer's disease with Leqembi. Patients who are in the mild cognitive impairment...
NovaBay Pharmaceuticals, a leading biopharmaceutical firm, delcares preliminary net revenue for the second quarter of 2024 of USD 2.4 million and for the first half of 2024 of $5.0 million, primarily derived from the firm's eyecare products. Net...
Indegene, a life sciences commercialization firm, has announced a strategic partnership with Microsoft to help global life sciences organizations accelerate the adoption of purpose-built, enterprise-grade Generative AI (GenAI) services, resulting...
The challenge of managing and mitigating impurities in drug products remains a critical focus with recent advancements in pharma. Impurities can pose serious health risks to patients and the presence of impurities can affect the safety.
For pharma, maintaining stringent cleaning standards is non-negotiable. The stakes are high, and the margin for error is slim. Cross-contamination can compromise product quality, endanger patient safety, and lead to costly regulatory penalties.
, CDSCO.jpg)
.jpg)